Tamoxifen-mediated growth inhibition of human cholangiocarcinoma

Cholangiocarcinoma represents a challenging primary malignancy of the liver with no effective medical therapy and a poor prognosis. We have investigated the role of tamoxifen and estrogen receptors (ERs) in the regulation of growth of human cholangiocarcinoma. Two human cholangiocarcinoma cell lines...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 1997-05, Vol.57 (9), p.1743-1749
Hauptverfasser:	SAMPSON, L. K, VICKERS, S. M, YING, W, PHILLIPS, J. O
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic agents Biological and medical sciences Blotting, Northern Cell Division - drug effects Chemotherapy Cholangiocarcinoma - drug therapy Cholangiocarcinoma - pathology Female Gene Expression Regulation, Neoplastic Growth Inhibitors - pharmacology Humans Liver Neoplasms - drug therapy Liver Neoplasms - pathology Medical sciences Mice Mice, Inbred BALB C Mice, Nude Pharmacology. Drug treatments Precipitin Tests Receptors, Estrogen - genetics Tamoxifen - pharmacology Tumor Cells, Cultured
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!